Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience
Hersh, E M, Metch, B S, Muggia, F M, Brown, T D, Whitehead, R P, Budd, G T, Rinehart, J J, Crawford, E D, Bonnet, J D, Behrens, B C
Published in Journal of immunotherapy (01.12.1991)
Published in Journal of immunotherapy (01.12.1991)
Get more information
Journal Article